Calliditas Therapeutics AB - ADR
News
Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
PR Newswire Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) PR Newswire STOCKHOLM, Sept. 3, 2024 STOCKHOLM, Sept. 3, 2024...\n more…
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
PR Newswire Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei PR Newswire...\n more…
-logo-1200x675.jpg?v=20221209114501&w=240&h=240&zc=2){kind=logo}
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Unusually-High Trading Volume
Ticker Report Calliditas Therapeutics AB (publ) (NASDAQ:CALT - Get Free Report) shares saw an uptick in trading volume on Tuesday . 8,040 shares changed hands during mid-day trading, a decline of 23% from the...\n more…
Head-To-Head Analysis: Calliditas Therapeutics AB (publ) (NASDAQ:CALT) versus Dyne Therapeutics (NASDAQ:DYN)
Ticker Report Calliditas Therapeutics AB (publ) (NASDAQ:CALT - Get Free Report) and Dyne Therapeutics (NASDAQ:DYN - Get Free Report) are both medical companies, but which is the superior investment? We will...\n more…
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Receives $35.00 Consensus Price Target from Analysts
Ticker Report Shares of Calliditas Therapeutics AB (publ) (NASDAQ:CALT - Get Free Report) have earned an average recommendation of "Hold" from the six analysts that are currently covering the stock, Marketbeat...\n more…
Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript
Seeking Alpha: Transcripts Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript...\n more…